2型糖尿病患者的皮质醇循环节律和萨尔科佩尼亚:一个横截面研究
Fupeng Liu1, Qing Yang2, Kai Yang1
1Department of Endocrinology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, China.
Journal of cachexia, sarcopenia and muscle
|February 17, 2025
概括
患有2型糖尿病 (T2DM) 和夜间皮质醇水平升高的患者面临更高的麻症风险. 这项研究强调了皮质醇中断的昼夜节律和T2DM患者的肌肉损失之间的关联.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 老年病的医生 老年病的医生
背景情况:
- 2型糖尿病 (T2DM) 与皮质醇异常模式有关,包括夜间水平升高和平坦的昼夜节律.
- 皮质醇的过分分泌会导致肌肉衰竭,肌肉强度和质量下降,可能导致肉症.
- 在T2DM患者中,皮质醇昼夜节律和肉症之间的关系需要进一步调查.
研究的目的:
- 调查T2DM患者中皮质醇昼夜节律和肉症之间的关联.
- 确定皮质醇模式是否被破坏有助于这种人群中 Sarcopenia 的发展.
主要方法:
- 评估了128名患有非功能性上腺腺瘤的T2DM患者.
- 使用CT扫描的骨肌肉指数 (SMI) 和骨肌肉密度 (SMD) 诊断出肉症.
- 皮质醇水平在上午8点,下午4点和午夜被测量;统计分析包括累积逻辑模型和ROC曲线.
主要成果:
- 与非sarcopenic患者相比,sarcopenic患者的午夜皮质醇水平显著更高 (Cor 0 AM) (p < 0.001).
- 午夜皮质醇水平与SMI和SMD负相关 (r = 分别为-0.318和-0.284;p <0.001).
- 较高的午夜皮质醇水平独立地与缩症的风险增加有关 (OR = 7.92; p = 0.017),而Cor 0 AM表现出强大的预测能力 (AUC = 0.760).
结论:
- 皮质醇中断的昼夜节律与T2DM患者的肉症显著相关.
- 较高的夜间皮质醇水平,而不是早晨或下午的水平,与较高的肉类的风险有关.
- 这些发现表明,在T2DM中进行的肉症研究中,这是一种新的治疗标.
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
531
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
531
Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28


